Is Jyothy Labs a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jyothy Labs Ltd is a good quality company .

Is Jyothy Labs undervalued or overvalued?

The key valuation ratios of Jyothy Labs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Jyothy Labs share price return in the past 10 years?

Jyothy Labs Ltd share price has appreciated 13.3% annually (CAGR) over the past ten years.

Is Jyothy Labs a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Jyothy Labs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Jyothy Labs Ltd - Stock Valuation and Financial Performance

Name: Jyothy Labs
Brand: Jyothy Labs

BSE: 532926 | NSE: JYOTHYLAB | Household & Personal Products | Small Cap

Place order

Jyothy Labs Share Price

₹404.20 -1.25 -0.31%
as on 22-Nov'24 16:59

10 Year X-Ray of Jyothy Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	10.6%	15.2%	16%	17.6%	16.9%	13.8%	16.6%	13.4%	20%	28.8%	-
Value Creation Index ⓘ	-0.3	0.1	0.2	0.3	0.3	0.0	0.2	0.0	0.5	1.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1,515	1,593	1,683	1,672	1,814	1,711	1,909	2,196	2,486	2,757	2,813
Sales YoY Gr.	-	5.1%	5.7%	-0.6%	8.4%	-5.7%	11.6%	15.1%	13.2%	10.9%	-
Adj EPS ⓘ	3.3	2	5.7	4.4	5.6	4.7	5.9	4.4	6	9.7	10.2
YoY Gr.	-	-38.4%	179.9%	-23.6%	27.5%	-15.7%	25.6%	-25.6%	37.9%	61.3%	-
BVPS (₹) ⓘ	20.7	23.7	29	30.6	36.1	33.5	38.9	39.3	42.2	49.2	51.4
Adj Net Profit ⓘ	120	74	208	158	204	172	216	161	222	358	376
Cash Flow from Ops. ⓘ	166	192	163	242	302	171	402	203	329	458	-
Debt/CF from Ops. ⓘ	3.4	2.4	3.1	2.3	0.9	1.7	0.3	0.6	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6.9%	8.7%	13%	10.9%
Adj EPS ⓘ	12.7%	11.9%	18.3%	61.3%
BVPSⓘ	10.1%	6.4%	8.2%	16.7%
Share Price	13.3%	17.5%	39%	-6.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	15.8	8.8	20.9	14.2	16.5	13.5	16.3	11.2	14.8	21.3	20.3
Op. Profit Mgn % ⓘ	10.9	14	15.2	15.4	15.5	14.7	16.5	11.3	12.7	17.4	17.7
Net Profit Mgn % ⓘ	7.9	4.4	12.1	9	10.8	9.6	10.9	7.2	8.9	13	13.4
Debt to Equity ⓘ	0.8	0.5	0.5	0.5	0.2	0.2	0.1	0.1	0	0	0
Working Cap Days ⓘ	127	136	142	154	130	144	130	122	116	125	77
Cash Conv. Cycle ⓘ	22	17	21	31	19	24	20	16	15	9	45

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 20.30%

Sales growth is growing at healthy rate in last 3 years 13.03%

Net Profit is growing at healthy rate in last 3 years 18.25%

Sales growth is not so good in last 4 quarters at 6.43%

Latest Financials - Jyothy Labs Ltd.

	Standalone	Consolidated
TTM EPS (₹)	10.2	10.2
TTM Sales (₹ Cr.)	2,810	2,813
BVPS (₹.) ⓘ	33.2	51.4
Reserves (₹ Cr.) ⓘ	1,183	1,849
P/BV ⓘ	12.09	7.82
PE ⓘ	39.23	39.24

From the Market
52 Week Low / High (₹)	366.70 / 595.00
All Time Low / High (₹)	10.51 / 595.00
Market Cap (₹ Cr.)	14,745
Equity (₹ Cr.)	36.7
Face Value (₹)	1
Industry PE ⓘ	62.5

Management X-Ray of Jyothy Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Jyothy Labs

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Jyothy Labs

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	1,515	1,593	1,683	1,672	1,814	1,711	1,909	2,196	2,486	2,757
Operating Expenses ⓘ	1,352	1,371	1,429	1,415	1,532	1,460	1,595	1,948	2,170	2,277
Manufacturing Costs	51	57	58	50	45	48	46	48	60	67
Material Costs	777	836	894	875	971	901	1,010	1,283	1,435	1,404
Employee Cost	165	166	165	178	193	208	222	238	260	295
Other Costs ⓘ	358	312	312	311	324	304	317	379	415	511
Operating Profit ⓘ	163	222	254	257	281	251	315	248	316	480
Operating Profit Margin (%)	10.8%	13.9%	15.1%	15.4%	15.5%	14.7%	16.5%	11.3%	12.7%	17.4%
Other Income ⓘ	10	14	11	62	28	20	18	19	40	54
Interest ⓘ	14	62	56	48	35	33	19	12	13	5
Depreciation ⓘ	33	31	30	31	31	53	56	58	50	50
Exceptional Items ⓘ	-2	0	0	0	0	-4	-24	0	7	0
Profit Before Tax ⓘ	125	143	179	241	243	182	235	197	299	479
Tax ⓘ	4	69	-26	62	45	19	44	38	59	110
Profit After Tax	121	74	204	179	198	163	191	159	240	369
PAT Margin (%)	8.0%	4.6%	12.1%	10.7%	10.9%	9.5%	10.0%	7.2%	9.6%	13.4%
Adjusted EPS (₹)	3.4	2.2	5.7	5.1	5.6	4.6	5.4	4.4	6.5	10.1
Dividend Payout Ratio (%)	60%	116%	52%	5%	54%	65%	74%	57%	46%	35%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	751	860	1,055	1,112	1,327	1,229	1,429	1,444	1,549	1,807
Share Capital ⓘ	18	18	18	18	37	37	37	37	37	37
Reserves ⓘ	733	842	1,037	1,094	1,290	1,192	1,392	1,407	1,512	1,771
Minority Interest	1	-3	-7	-14	-21	-29	-38	-41	2	2
Debt	449	7	55	281	217	221	117	127	0	0
Long Term Debt	449	7	6	4	2	0	0	0	0	0
Short Term Debt	0	0	49	277	215	221	117	127	0	0
Trade Payables	132	161	149	151	179	130	192	236	214	276
Others Liabilities ⓘ	579	881	663	574	412	477	488	525	627	757
Total Liabilities ⓘ	1,913	1,907	1,916	2,103	2,114	2,027	2,187	2,291	2,392	2,842
Fixed Assets
Gross Block	1,298	1,096	1,154	1,176	1,205	1,305	1,356	1,376	1,413	1,451
Accumulated Depreciation	202	28	57	85	104	156	209	255	296	326
Net Fixed Assetsⓘ	1,096	1,068	1,097	1,091	1,101	1,149	1,147	1,122	1,116	1,125
CWIP ⓘ	16	8	9	15	14	24	10	8	15	13
Investmentsⓘ	194	86	28	113	104	0	0	0	0	192
Inventories	185	185	196	188	202	225	279	297	302	284
Trade Receivables	57	94	117	161	153	122	94	143	138	201
Cash Equivalents	75	61	103	137	96	29	194	211	283	166
Others Assetsⓘ	290	405	364	398	442	477	464	510	537	861
Total Assets ⓘ	1,913	1,907	1,916	2,103	2,114	2,027	2,187	2,291	2,392	2,842

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	166	192	163	242	302	171	402	203	329	458
PBT ⓘ	125	143	179	241	243	182	235	197	299	479
Adjustment ⓘ	60	98	81	30	60	81	95	63	35	20
Changes in Working Capital ⓘ	23	3	-66	-4	41	-53	105	-26	51	39
Tax Paid ⓘ	-42	-52	-31	-25	-42	-39	-33	-31	-57	-79
Cash Flow From Investing Activity ⓘ	-26	108	-17	-74	30	72	-129	-32	-48	-344
Capex	-16	-26	-57	4	-38	-42	-26	-21	-12	-14
Net Investments	-19	130	32	-85	63	112	-105	-13	-43	-351
Others ⓘ	9	4	7	6	5	2	1	3	7	21
Cash Flow From Financing Activityⓘ	-18	-302	-130	-145	-318	-304	-216	-167	-251	-135
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	38	-2	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-14	-10	-156	-60	-34	-21	-28	-7	-10	0
Dividend Paid ⓘ	-36	-145	-18	-109	-18	-220	0	-147	-92	-110
Others ⓘ	-6	-146	44	24	-266	-62	-188	-12	-148	-25
Net Cash Flow ⓘ	123	-2	16	23	13	-60	57	4	30	-21

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	16.29	9.16	21.32	16.51	16.2	12.73	14.35	11.08	16.02	22.01
ROCE (%)	10.57	15.17	16	17.63	16.89	13.75	16.61	13.4	20.03	28.81
Asset Turnover Ratio	0.85	0.87	0.92	0.84	1.03	0.99	1.1	1.19	1.29	1.29
PAT to CFO Conversion(x)	1.37	2.59	0.8	1.35	1.53	1.05	2.1	1.28	1.37	1.24
Working Capital Days
Receivable Days	14	17	22	30	26	24	17	16	17	18
Inventory Days	42	41	40	42	33	38	39	39	36	32
Payable Days	57	64	63	63	62	63	58	61	57	64

Jyothy Labs Ltd Stock News

Jyothy Labs Ltd FAQs

What is the share price of Jyothy Labs?

Company share prices are keep on changing according to the market conditions. The closing price of Jyothy Labs on 22-Nov-2024 16:59 is ₹404.2.

What is the market cap of Jyothy Labs?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Nov-2024 16:59 the market cap of Jyothy Labs stood at ₹14,745.3.

What is the P/E ratio of Jyothy Labs?

The latest P/E ratio of Jyothy Labs as of 22-Nov-2024 16:59 is 39.23.

What is the P/B ratio of Jyothy Labs?

The latest P/B ratio of Jyothy Labs as of 22-Nov-2024 16:59 is 12.09.

What is the 52-week high and low of Jyothy Labs?

The 52-week high of Jyothy Labs is ₹595.0 and the 52-week low is ₹366.7.

What is the TTM revenue of Jyothy Labs?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jyothy Labs is ₹2,810 ( Cr.) .

About Jyothy Labs Ltd

Jyothy Laboratories Limited began its journey in 1983 with a single product – Ujala Supreme – in the fabric whitener category. The product was woven around a unique proposition. An iconic jingle ‘Aaya naya Ujala, chaar boondo waala’ was created to market this product. The message to the consumer was that now spotlessly clean clothes were possible by using only four drops of Ujala Supreme. Over the years, the company invested in market and product research to diversify into various household product categories such as insecticides, fabric stiffeners and soap, leading to the launch of successful products like Ujala, Maxo and Exo.

A turning point was reached in 2011, with the company’s acquisition of a controlling stake in Henkel India, the local arm of the German FMCG giant Henkel AG & Co. This business association widened the company’s opportunity landscape as consumer business segments of Jyothy Laboratories and this global giant were clubbed. The company’s pan India presence covers many manufacturing facilities and two research and development centres. Most of the company’s plants are proximate to major consumption centres and tax-friendly zones.

Business area of the company

The company is in the business of meeting the everyday needs of consumers by creating well-packaged and technologically advanced products in four segments of the fast-moving consumer goods industry. It has offerings in fabric care, dish wash, household insecticide and personal care. Its brands are household names such as Ujala, Henko, Exo, Pril, Maxo and Margo. It is also in the business of laundry services.

Key product categories

Fabric care
Dish wash
Household insecticides
Personal care
Laundry services

Awards

2016-17: DQ Vertical Warrior Award for Innovative use of Technology in FMCG Vertical.
2016-17: IDC Insights Award for Excellence in Operations 2016.
2016-17: At Jyothy Laboratories, the year 2016-17 was eventful during which it was recognised for a new product launch and for innovation in IT.
2017-18: Janam Global Excellence Award 2018 presented by Janam TV.
2017-18: Business Reliability Award 2017 presented by Reporter Channel.
2017-18: Malayalee Business Achiever Award 2018 presented by Pegasus Group.
2017-18: IDC Insights Awards 2017 for excellence in operation.
2018-19: Jyothy Labs was conferred with commendation certificate by IMC Ramakrishna Bajaj National Quality Award in the ‘Manufacturing Category’.
2019-20: Jyothy Labs was acknowledged amongst the Top Organisations with Innovative HR Practices at the 18th Edition Asia Pacific HRM Congress.

Milestones

1983: Jyothy Laboratories was started by M P Ramachandran as a proprietary concern in Kerala. Ujala was launched.
1984: Ujala was sold door to door by team of six sales people in the Trichur and Malappuram districts of Kerala.
1986: Jyothy Laboratories releases its first print advertisement in the Kerala-based Mathrubhoomi newspaper.
1987: It also entered in the market of Tamil Nadu.
1992: The company set up factory located at Chennai to manufacture Ujala.
1992: The same year the company was incorporated.
1994: The company set up a plant In Pondicherry.
1995: The company launched Nebula, an oil-based antibacterial washing soap in Kerala
1997: Jyothy Laboratories launches Ujala all over India.
2000: The company launched Maxo (mosquito repellent) in West Bengal. It also launched Exo (antibacterial dish wash bar) in Kerala, Karnataka, Tamil Nadu and Andhra Pradesh.
2001: The company forayed into manufacturing of incense stick business and launched Maya.
2002: JLL acquired Sri Sai Homecare, which has a mosquito coil production facility in Hyderabad.
2002: The company launched Jeeva Ayurvedic Soap
2005: Jyothy launched Xo Liquid and Ujala Stiff and Shine in South India.
2007: The company entered into deed of assignment of trademark and copyright for the More Light and Ruby brands.
2008: JIL launched Ujala Stiff & Shine all over India.
2010: Jyothy Laboratories Ltd launches multi-insect repellent in technological association with DRDO''2011 - DRDO (Ministry of Defence) ties up with Jyothy Laboratories Ltd to fight insect menace2012 - Jyothy Labs - Henkel India Ltd to merge with Jyothy Laboratories Ltd.
2013: Jyothy Laboratories to set up subsidiary in Bangladesh
2013: Jyothy Laboratories own Emerging India Award for the year 2013
2014: Jyothy Laboratories own Indian Marketing Awards for the year 2014.
2014: Jyothy Laboratories own India Star Packaging Award for the year 2014.
2016: Jyothy Lab gets nod to merge subsidiary with itself.
2017-18: Launched two innovative products in the market - T-Shine and Maxo Incense Sticks, both of which are path-breaking in their respective categories.
2018-19: New Margo Glycerine with goodness of thousand neem leaves and pure glycerine launched
2018-19: Ujala Crisp & Shine ‘Gold Collection‘ launched
2019-20: Launched Margo Handwash and Margo Sanitizer.
2019-20: The company has launched smaller packs of Pril Liquid.